Delivery Order SPE2DB20D1100-SPE2DB25FA5F5
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,905.74 firm fixed-price delivery order is for the supply of MOVANTIK 12.5 MG TABLET 30S, with a completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $7,343.92 for the supply of the drug Movantik 25 mg in tablet form. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award SPE2DB20D1109|SPE2DB25FN00X, valued at $9,076.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication MOVANTIK 25 MG TABLET 30S and has a completion date of October 31, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Movantik 25 mg tablets to the Defense Logistics Agency (DLA). The $1,174.80 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical...
- This is a $6,470.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The order has an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
- The Defense Logistics Agency (DLA) awarded a $1,045.62 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of MOVANTIK 25 MG TABLET UD 100S. This contract has an ultimate completion date of September 30, 2024 and is not a set-aside. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a...
- The Defense Logistics Agency issued a $3,253.70 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for Movantik 25 mg tablets (30-count units), with a completion date of March 10, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which provides pharmaceutical and medical supply support to military healthcare programs worldwide. Place of performance is Conshohocken, PA. The order carries...
- The Defense Logistics Agency awarded a delivery order valued at $3,100.99 to AmerisourceBergen Drug Corp for the supply of Movantik (naloxegol) 25 mg tablets in a quantity of 30 units. The contract, awarded on November 26, 2025, represents a firm fixed-price delivery order with an ultimate completion date of November 28, 2025, and carries no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location....
- The Defense Logistics Agency issued a $1,033.74 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Movantik (naloxegol) 25 mg tablets. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an ultimate...
- <p>The Defense Logistics Agency issued a $4,687.45 delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for supply of Movantik 12.5 mg tablets (30-count packages). The order was issued under the company's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and running through December 2026.</p> <p>Place of performance is Conshohocken, PA. The ultimate completion date is March 13, 2026. Pricing is firm fixed price. No set-aside was used.</p>
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FA5F5Delivery Order
This federal contract award, valued at $1,566.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product, with a completion date of February 10, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 2/7/25 |